THE life SCIENCE
Trusted medical news for healthcare professionals
Saturday, 25 April 2026
Today on The Life Science Feed

Highlights

Newsletter
Sign up for one of our newsletters and stay ahead in Life Science
I have read and understood the Privacy Notice and would like to register on the site. *
I consent to receive promotional and marketing emails from The Life Science Feed. To find out how we process your personal information please see our Privacy Notice.
* Indicates mandatory field
News
General Practice|Health Literacy and Lung Cancer Diagnostic DelaysEndocrinology|Can Routine CT Scans Predict Osteoporosis Risk?Hepatology|Using Growth Charts in Alagille SyndromeHaematology|Hemophilia Normalization's Price Tag and Policy ImplicationsEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksGeneral Practice|Health Literacy Gaps and Lung Cancer Diagnosis: A Policy PerspectiveEndocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal Risks and Glycemic ControlCardiology|SSEPs to Monitor Cerebral Perfusion During TCAR TAVR ProceduresGastroenterology|Endoluminal Markers Predict Crohn's Treatment FailureEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Haematology|Moving Beyond Deficiencies: Normalization Strategies in Hemophilia CareGeneral Practice|Health Literacy and Lung Cancer Diagnostic DelaysEndocrinology|Can Routine CT Scans Predict Osteoporosis Risk?Hepatology|Using Growth Charts in Alagille SyndromeHaematology|Hemophilia Normalization's Price Tag and Policy ImplicationsEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksGeneral Practice|Health Literacy Gaps and Lung Cancer Diagnosis: A Policy PerspectiveEndocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal Risks and Glycemic ControlCardiology|SSEPs to Monitor Cerebral Perfusion During TCAR TAVR ProceduresGastroenterology|Endoluminal Markers Predict Crohn's Treatment FailureEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Haematology|Moving Beyond Deficiencies: Normalization Strategies in Hemophilia Care